Xontogeny

Deep experience to guide your innovation

shape
shape mobile

Xontogeny’s team has experience across scientific diligence, drug and medical technology development and operations from preclinical stages through commercialization. Through the efforts of the team, Xontogeny supports and stays connected with its entrepreneurs and larger community of collaborators by providing strategic and investment leadership to create successful outcomes across its portfolio of companies.

Team

Chris Garabedian

Chairman & CEO

Fred Callori

EVP, Corporate Development

Ben Askew, Ph.D.

Partner,
Research & Development

Katherine Ruf

VP, Legal

Gianna Hoffman-Luca, Ph.D.

Principal

Takeru Furuya, Ph.D.

Senior Associate

Wendy Cort

Director, Administration

Heather Petty

Director, Program Development

Thien Nguyen, Ph.D.

Associate

Jayanth Batchu

Entrepreneur in Residence

Brad Murray

Advisor

Shobha Parthasarathi, Ph.D.

Advisor

Holly Purcell

Advisor

Melissa Rewolinski, Ph.D.

R&D Advisor

Ann Taylor, M.D.

R&D Advisor

Ben Green

Digital Strategy Advisor

Dana Leone

Advisor

Robin Wallace

Clinical Operations Advisor
shape
shape mobile

Board

Chris Garabedian

Chris Garabedian founded Xontogeny in June of 2016 to support multiple promising technologies from early development through clinical proof of concept.

Joe Edelman

Joe Edelman founded the hedge fund Perceptive Advisors, LLC in 1999, to further the progress of promising companies within the life sciences industry.

Adam Stone

Adam Stone joined Perceptive Advisors, a hedge fund focused on supporting the progress of the life sciences industry, in 2006.